SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as the stock surged to record highs and briefly joined the trillion-dollar market-capitalization club for the first time, amid a broader semiconductor rally driven by AI and data-center demand. The community is split between bulls celebrating the milestone and bears warning the stock is overvalued and due for a pullback, with some traders also attributing the move to a short squeeze or manipulation.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is surging double digits alongside a broad semiconductor rally, with traders widely attributing the move to agentic-AI CPU demand  much of the chatter crediting adoption of Meta's Muse AI agent  reinforced by the CEO's remark that Intel can currently meet only about half of customer CPU demand, and some citing heavy short covering. The community is split between bulls calling the breakout the start of a bigger run and skeptics calling the stock overextended, pointing to ongoing losses and market-share erosion.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Shares sold off sharply after Novo Nordisk's Capital Markets Day, where long-term pipeline targets and guidance for only mid-single-digit revenue growth through 2030 failed to ease concerns about Eli Lilly competition and looming semaglutide patent expirations. The community is split: many traders blast the outlook and CEO Mike Doustdar's communication, with some calling for leadership changes or M&A such as a Viking Therapeutics deal, while bulls call the reaction overdone and are buying the dip, citing oversold levels, strong oral Wegovy uptake, and a positive CagriSema readout versus tirzepatide in type 2 diabetes.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals is surging after the U.S. announced a security agreement with Denmark and Greenland granting Washington permanent security access to the island, drawing renewed attention to its Tanbreez rare-earth project as a Western alternative to Chinese supply. Retail traders are largely bullish, framing the move as a potential short squeeze given elevated short interest, while skeptics note the deal has yet to be formally signed and question the pre-revenue company's fundamentals.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

SOXS is trending as the 3x inverse semiconductor ETF slides toward new lows amid a broad chip-stock rally, with SOXX and memory names like Micron breaking above key resistance and squeezing bears. Traders are split between adding to the position on expectations of an AI/semiconductor pullbackciting bubble concerns, hawkish Fed rate talk, and rising oiland warnings that continued sector strength and leveraged-ETF decay will keep punishing the trade.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Traders are debating a sharp tech-led rally that many attribute to falling oil prices on hopes of US-Iran de-escalation at UN talks, a move that shrugged off the Fed's latest rate hike and elevated yields. Bulls are riding the momentum with heavy 0DTE call buying printing outsized gains, while bears call it a manipulated, unsustainable pump and warn of a bull trap.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Reports that Paramount is in advanced settlement talks with California's attorney general to resolve the state-led antitrust suit blocking its Warner Bros. Discovery merger are driving attention, with discussed terms reportedly including a major California production investment, film-release commitments, and CNN editorial safeguards. Many traders view the talks as clearing a path for the deal to close, while others denounce the potential concessions as a political shakedown and argue Paramount should reject them or relocate rather than settle.

Maase, Inc. operates as a integrated provider and operator of artificial intelligence (AI) centric full-scene digital systems. The firm focus on areas of flexible energy deployment and intelligent commercial network operation, and provide closed-loop solutions from computing infrastructure, smart hardware and full-scene services, aiming to achieve large-scale implementation of AI technologies across industries. The company was founded by Hai Feng Yu on August 6, 2018 and is headquartered in Qingdao, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

A rapid series of enterprise AI contract announcements  AI compute capacity leases and prepaid token-based API agreements of escalating size  is dominating the discussion, with bulls framing the deal flow as a shift from one-off projects toward recurring, subscription-style revenue while skeptics note the stock isn't reflecting the news and question whether contracts will convert into recognized revenue, margins, and cash. Conversation also centers heavily on the company's AI security white paper for its Lingyan Miaoyu LLM, which many traders cite as a credibility step toward enterprise adoption.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is surging and testing a long-standing resistance level that has capped rallies for months, with bulls celebrating heavy short liquidations and Bitcoin's broader rebound while skeptics warn the breakout will fail as previous attempts did. The rally comes after the Clarity Act's Senate failure, with community attention turning to SEC and CFTC crypto rulemaking as the next regulatory development.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is swinging with the broader crypto market as traders digest the Senate's failure to advance the CLARITY Act, the CFTC's plan to issue its own crypto rules, and the Fed rate decision, with many viewing Bitcoin's direction as the key driver of DOGE's moves. The community is split between bulls treating the weakness as a buying opportunity as shorts get squeezed out and bears calling for further downside, while some point to Bitwise's liquidation of its Dogecoin ETF as a potential contrarian bottom signal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX from the perspective of an international (non-US) shareholder, the more acceptance ANKTIVA  receives internationally, the less important the US acceptance is. In my opinion, even if the USA FDA stall and/or reject the application short term there will eventually be a tipping point when the international community will force the FDA’s to act because the market acceptance and results will be so overwhelming that they will have no choice but to approve. This is a multi-generational, once in a lifestyle paradigm shift on how cancer is treated and I’m glad I could buy in now, because once the boat is missed, it’s missed forever.

Arnold

Ethel F

Earl Odie Chapultapec

Trina Aguirre

Marc Rothman

The Big Cheese

Muddy Waters

HeadHunter

cyberInvest

Proppa Bear

KnysnaNow

Topmost

mr mulally

"Veg"

Bruce Wayne

Robert N

BeautifulBiosInGreen

Gus McNulty

Nick

E.B. Matlack

Andy maslin

BullStock2016

LMAO

Rob Mazzetti

Ulaughing

Jeffrey Ponn

John Morin

Kenneth Orthner

vincent DeLuca

$IBRX come on let’s be serious…. The money is in America. The patients that need this the most are in America. Europe has an entirely different lifestyle to the US re: rates of cancer …The United States generally has a higher cancer incidence (new cases) than Europe, particularly for common cancers like breast and prostate, driven by more aggressive screening, higher obesity rates, and diagnostic practices. Mortality rates are just higher in Europe because they lack early detection habits.

StockTwits for iOS

SigneAlma

ImmunityBio Inc

 from the perspective of an international (non-US) shareholder, the more acceptance ANKTIVA  receives internationally, the less important the US acceptance is. In my opinion, even if the USA FDA stall and/or reject the application short term there will eventually be a tipping point when the international community will force the FDA’s to act because the market acceptance and results will be so overwhelming that they will have no choice but to approve. This is a multi-generational, once in a lifestyle paradigm shift on how cancer is treated and I’m glad I could buy in now, because once the boat is missed, it’s missed forever.